| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Steven Michael Oliveira last filed a Form 4 in April 2021, as 10% Owner at FBRX. The filings on record cover 2 companies. Steven Michael Oliveira's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Steven Michael Oliveira a below-average insider score of 21/100, based on 6 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -74.4%.
At the last filing, the largest reported position was 2,873,450 shares of FBRX. Net of sales, the FBRX filings show accumulation of 139,450 shares.
Steven Michael Oliveira has 3 Form 4 filings on record from March 2020 to April 2021, across 2 companies: 10% Owner at Benitec Biopharma (BNTC), 2021; 10% Owner at Forte Biosciences (FBRX), 2020.
The 8 reported transactions were 8 open-market purchases.
Counted by filing, the open-market trades come to 3 purchases worth about $1.7M and no sales.
The largest open-market purchase was 331,877 shares of BNTC at an average $4.51 on December 9, 2021, about $1.5M. Twelve months later BNTC was down 94%.
Shares as reported in the last Form 4 for each company; the most recent is from April 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.